Introduction 130
Eggs are a major source of dietary cholesterol. However, they are also an 131 inexpensive source of unsaturated fat, high-quality protein, folate, and other 132 vitamins and minerals (1,2). Dietary cholesterol contributes modestly to plasma 133 concentration of low-density lipoprotein (LDL) cholesterol (3), an well-known risk 134 factor for cardiovascular disease (CVD) (4). Dietary cholesterol has also been 135 directly associated with a higher risk of CVD (5). Because egg yolk is rich in 136 cholesterol, egg consumption is usually not recommended to subjects with 137 hypercholesterolemia, high cardiovascular risk or established CVD (6,7). 138
Egg consumption was directly associated with carotid plaque area in a cross-139 sectional study conducted among Canadian subjects at high cardiovascular risk 140 (8), but not in a cohort of middle-aged Finnish participants without coronary 141 heart disease (9). On the other hand, the association between egg consumption 142 and the risk of CVD is controversial. Li et al (10), found in a meta-analysis that 143 egg consumption was directly associated with CVD. However, in another meta-144 analysis of prospective cohort studies, Shin et al (11) , found that egg 145 consumption was not associated with CVD risk in the general population. In a 146 third meta-analysis of prospective cohort studies, Rong et al (12), reported that 147 higher consumption of eggs was also unassociated with coronary heart disease 148 or stroke. Interestingly, the three meta-analyses consistently found a direct 149 association between egg consumption and CVD in diabetic individuals. However, 150 most studies included in these meta-analyses were from the U.S. and other 151
Western countries, but studies from Mediterranean countries are scarce (13) . 152
The PREDIMED study provides a unique opportunity to assess prospectively the 153 association between egg comsumption and CVD in participants who were at high 154 cardiovascular risk, nearly 50% of whom had type 2 diabetes. This half-and-half 155 distribution of exposure to diabetes allowed us to obtain an ideal setting to 156 ascertain the association between egg consumption and CVD incidence 157 according to diabetic status. We aimed to examine the association between egg 158 consumption and CVD in a high cardiovascular risk cohort stratified by diabetic 159
status. 160 161
Methods 162
Study design and subjects 163
The current cohort study was conducted within the framework of the 164 PREDIMED study (PREvención con DIeta MEDiterránea). The PREDIMED 165 study is a parallel-group, multicenter, randomized, and controlled field trial. 
practitioners. 173
Eligible participants were men aged 55-80 years and women aged 60-80 years 174 who were free of CVD at baseline and had either type 2 diabetes or at least 175 three of the following cardiovascular risk factors: hypertension (blood pressure 176 >140/90 or treatment with antihypertensive medication); elevated LDL 177 cholesterol concentration (160mg/dl or lipid lowering therapy); low high-density 178 lipoprotein (HDL) cholesterol concentration (  40mg/dl in men or ≤50 mg/dl in 179 women); obesity or overweight; current smoking; and family history of 180 premature coronary heart disease. All participants provided written informed 181 consent to a protocol approved by Institutional Review Boards of all 182 participating PREDIMED centers at study inception. 183
We excluded participants with missing baseline dietary information (n=78) or 184 whose caloric intakes were outside of predefined limits (<800 or >4000 kcal/day 185 for men and <500 or >3500 kcal/day for women; n=153). Thus, the final sample 186 analyzed was 7216 participants (48.9% of them with type 2 diabetes). 187
188

Clinical and dietary measurements 189
Baseline dietary intake was ascertained with a 137-item semi-quantitative food-190 frequency questionnaire (FFQ) with 137 items, validated in an old population 191 with high cardiovascular risk in Spain (17) . The FFQ was administered at 192 baseline and yearly during the trial. We used an incremental scale with 9 levels, 193 which ranged from "never or almost never" to ">6 times/day", to collect 194 information on the frequencies of consumption of food items. Energy and 195 nutrient intakes were computed by using Spanish food composition tables (18). 
218
Statistical analyses 219
Participants were divided into 3 categories of egg consumption (<2, 2-4 and >4 220 eggs/week). The residuals method was used to adjust egg consumption for total 221 energy intake (22). We summarized quantitative variables by their mean and 222 standard deviation (SD), and categorical variables using percentages. 223
We fitted Cox regression models to calculate hazard ratios (HR) and their 95% 224 confidence intervals (CI) between egg consumption and major CVD events. The 225 group with the lowest consumption (<2 eggs/week) was used as the reference 226 category. The entry time was the date at recruitment. The exit time was defined 227 as the date at myocardial infarction, stroke, or death from cardiovascular 228 causes or June 30th 2012, whichever came first. 229
To minimize any effects of a change in diet, we calculated a cumulative sum of 230 egg consumption by using yearly updated information from repeated FFQs 231 collected at baseline and yearly thereafter up to 8 years of follow-up for each 232 participant. Besides the baseline questionnaire, our participants completed 5.3 233 yearly food-frequency questionnaires, on average, during follow-up. These data 234 were used to fit Cox regression models to assess the association between the 235 cumulative sum of egg consumptions and the risk of CVD in the subsequent 236 year. First we adjusted only for age (continuous), sex, BMI (continuous), and 237 intervention group and stratified by recruitment center. In a second model, 238 additional adjustments for smoking status (never smoker, quitters, current 239 smoker), physical activity during leisure time (continuous), and educational 240 status (3 categories) were performed. Model 3 was further adjusted for diabetes 241 (yes/no), hypertension (yes/no), hypercholesterolemia (yes/no), and family 242 history of premature coronary heart disease (yes/no). In the fully adjusted 243 model, we additionally adjusted for Mediterranean diet score (continuous), 244 alcohol intake (continuous), and total energy intake (continuous). 245
We assigned the median of the category to all participants in the category and 246 treating it as a continuous variable to conduct tests of linear trend across 247 increasing categories of egg consumption. 248
All P values were 2-sided, and significance was set at p<0.05. Analyses were 249 performed using STATA software, version 12.0 (Stata Corp, College Station, 250
TX, USA). 251 252 253
Results
254
A total of 8713 candidates were screened for eligibility, and 7447 participants 255
were randomly assigned to one of the three intervention groups. Of them, 153 256 subjects who were outside the limits for total energy intake at baseline were 257 excluded. We also excluded 78 participants with missing baseline dietary 258 information. Thus the analyses were carried out on 7216 participants. 259
After a mean follow-up of 5.8 years, 342 participants had a myocardial 260 infarction, a stroke or died from a cardiovascular cause. The main 261 characteristics of the 7216 participants of the PREDIMED study according to 262 baseline egg consumption are shown in Table 1 . In this cohort, 3.0% of the 263 participants consumed >4 eggs/week and 34.8% consumed <2 eggs/week. 264
Participants reporting >4 eggs/week were younger and had a higher physical 265 activity level, better educational attainment, and higher total energy and alcohol 266 intake. They were also more likely to be male and current smokers, and to take 267 antiplatelet drugs or oral hypoglycemic drugs, but less likely to be treated with 268 insulin than participants reporting consumption of less than 2 eggs/week. 269
Participants with the lowest consumption (<2 eggs/week) were more likely to 270 have dyslipidemia or hypertension and to be treated with statins, β-blockers or 271 calcium channel blockers than participants reporting the highest level of 272 consumption (>4 eggs/week). During follow-up, 61% of the participants in the 273 <2 eggs/week category at baseline, stayed always in the lowest category of egg 274 consumption. On the other hand, 44% of the participants in the >4 eggs/week 275 category at baseline, stayed always in the highest category of egg consumption 276 during follow-up. Finally, those participants with baseline egg consumption 277 between 2 and 4 eggs/week, increased ever their consumption in 2% of the 278 cases and decreased it ever in 17% of the cases. 279
Using as the reference category the group of participants who reported the 280 lowest egg consumption (<2 eggs/week), participants who reported a higher 281 consumption did not show a significantly higher risk of CVD (Table 2) (Table 2) . 291
A total of 117 primary-outcome events occurred in participants without diabetes 292 at baseline (n=3689). Using as reference category non-diabetics who had the 293 lowest egg consumption (<2 eggs/week), those who reported a consumption of 294 2-4 eggs/week had a HR of 1.09 (95% CI: 0.73-1.62) and those with a 295 consumption >4 eggs/week had a HR of 0.96 (95% CI: 0.33-2.76) in the fully 296 adjusted model (Table 2 ). The test for interaction between egg consumption 297 and diabetes at baseline was not significant (P=0.80). 298
Neither intervention groups (Mediterranean diet) nor the control group showed 299 an association of egg consumption with the primary outcome ( Table 2) . 300
Interaction between intervention group (Mediterranean diet groups versus 301 control) was not significant (P=0.49) 302
In the cumulative dietary analyses using sum of repeated measurements of egg 303 consumption we found similar results with no significant association between 304 egg consumption and CVD ( Higher baseline egg consumption was not associated with CVD in our 311
Mediterranean cohort of older subjects at high cardiovascular risk. Egg 312 consumption in this cohort was lower than that reported in others studies 313 (7,8,9). Indeed, only 3% of the participants in our study consumed >4 314 eggs/week at baseline. In our study, egg consumption was unrelated to an 315 increased risk of CVD in patients with diabetes and in those without diabetes. 316
However, when we compared extreme categories of consumption we found 317 higher point estimates for diabetics than for non-diabetics. Therefore, our 318 results are compatible with the hypothesis that diabetic patients may be more 319 sensitive to egg consumption and that very high egg consumption among 320 diabetics may predispose them to a higher risk of developing CVD. 321
A mechanism that might explain the lack of association between egg 322 consumption and incident CVD is that egg consumption promotes the creation 323 of large LDL particles that are less atherogenic (23). These changes have also 324 been observed in elderly individuals (24). Additionally, in hyperlipidemic adults 325 treated with lipid-lowering drugs (around 40% of our participants were statin 326 users) the consumption of 3 additional eggs/day increased HDL-cholesterol and 327 decreased the LDL:HDL ratio (25). Furthermore, egg yolk contains inhibitors of 328 platelet activating factor that reinforce their value in CVD protection (26). In a 329 12-week randomized trial the effect of a hypoenergetic high-protein high-330 
Mediterranean dietary pattern has beneficial effects on cardiovascular risk 355
factors, lowers the total cholesterol: HDL cholesterol ratio and reduces the 356 incidence of major cardiovascular events (11,13). 357
We recognize that our study has some limitations. First, only 3% of our 358 participants consumed >4 eggs/week, which hampers the capacity to detect 359 associations between higher egg consumption and CVD. Second, the effect of 360 the dietary intervention may have modulated the effect of egg consumption on 361 CVD incidence. The method used for dietary assessment was a food-frequency 362 questionnaire, with the potential for misclassification bias. However, the FFQ 363 was extensively validated, and the estimated cumulative sum of consumption 364 may have been more robust than with a one-time assessment. Third, although 365 we adjusted for many covariates, residual confounding cannot be completely 366 excluded. Finally, the generalizability of these results is limited because our 367 study is a non-representative sample of the general Spanish population, as it is 368 a high-cardiovascular risk cohort. However, having around 50% of diabetic 369 patients, allowed us to study the association between egg consumption and 370 cardiovascular risk in people with and without type 2 diabetes. 371
Our study also has strengths: the prospective design, a large sample size, a 372 long period of follow-up, the use of repeated dietary egg consumption measures 373 during follow-up, and adjustment for a wide array of confounders. 
